These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29439519)

  • 1. Biochemical Mechanism of Rhododendrol-Induced Leukoderma.
    Ito S; Wakamatsu K
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439519
    [No Abstract]   [Full Text] [Related]  

  • 2. 4-(4-Hydroxyphenyl)-2-butanol (rhododendrol)-induced melanocyte cytotoxicity is enhanced by UVB exposure through generation of oxidative stress.
    Goto N; Tsujimoto M; Nagai H; Masaki T; Ito S; Wakamatsu K; Nishigori C
    Exp Dermatol; 2018 Jul; 27(7):754-762. PubMed ID: 29630780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
    Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
    J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosinase-catalyzed metabolism of rhododendrol (RD) in B16 melanoma cells: production of RD-pheomelanin and covalent binding with thiol proteins.
    Ito S; Okura M; Nakanishi Y; Ojika M; Wakamatsu K; Yamashita T
    Pigment Cell Melanoma Res; 2015 May; 28(3):295-306. PubMed ID: 25713930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosinase-catalyzed oxidation of rhododendrol produces 2-methylchromane-6,7-dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity.
    Ito S; Ojika M; Yamashita T; Wakamatsu K
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):744-53. PubMed ID: 24903082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.
    Abe Y; Okamura K; Kawaguchi M; Hozumi Y; Aoki H; Kunisada T; Ito S; Wakamatsu K; Matsunaga K; Suzuki T
    J Dermatol Sci; 2016 Jan; 81(1):35-43. PubMed ID: 26547111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tyrosinase is able to oxidize both enantiomers of rhododendrol.
    Ito S; Gerwat W; Kolbe L; Yamashita T; Ojika M; Wakamatsu K
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1149-53. PubMed ID: 25130058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potent pro-oxidant activity of rhododendrol-eumelanin is enhanced by ultraviolet A radiation.
    Ito S; Agata M; Okochi K; Wakamatsu K
    Pigment Cell Melanoma Res; 2018 Jul; 31(4):523-528. PubMed ID: 29474003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potent pro-oxidant activity of rhododendrol-eumelanin induces cysteine depletion in B16 melanoma cells.
    Ito S; Okura M; Wakamatsu K; Yamashita T
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):63-67. PubMed ID: 28132436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism.
    Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of CD86 and IL-12 by rhododendrol in THP-1 cells cocultured with melanocytes through ROS and ATP.
    Katahira Y; Sakamoto E; Watanabe A; Furusaka Y; Inoue S; Hasegawa H; Mizoguchi I; Yo K; Yamaji F; Toyoda A; Yoshimoto T
    J Dermatol Sci; 2022 Dec; 108(3):167-177. PubMed ID: 36610941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinase-Catalyzed Oxidation of the Leukoderma-Inducing Agent Raspberry Ketone Produces (E)-4-(3-Oxo-1-butenyl)-1,2-benzoquinone: Implications for Melanocyte Toxicity.
    Ito S; Hinoshita M; Suzuki E; Ojika M; Wakamatsu K
    Chem Res Toxicol; 2017 Mar; 30(3):859-868. PubMed ID: 28219012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rhododendrol and its metabolic products on melanocytic cell growth.
    Okura M; Yamashita T; Ishii-Osai Y; Yoshikawa M; Sumikawa Y; Wakamatsu K; Ito S
    J Dermatol Sci; 2015 Nov; 80(2):142-9. PubMed ID: 26282085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
    Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
    J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative Oligomerization of DBL Catechol, a potential Cytotoxic Compound for Melanocytes, Reveals the Occurrence of Novel Ionic Diels-Alder Type Additions.
    Sugumaran M; Umit K; Evans J; Muriph R; Ito S; Wakamatsu K
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper chelation by d-penicillamine alleviates melanocyte death induced by rhododendrol without inhibiting tyrosinase.
    Nagatani K; Abe Y; Homma T; Fujii J; Suzuki T
    Biochem Biophys Res Commun; 2023 Jun; 663():71-77. PubMed ID: 37119768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
    Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
    J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A convenient screening method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols.
    Ito S; Wakamatsu K
    J Dermatol Sci; 2015 Oct; 80(1):18-24. PubMed ID: 26228294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhododenol and raspberry ketone impair the normal proliferation of melanocytes through reactive oxygen species-dependent activation of GADD45.
    Kim M; Baek HS; Lee M; Park H; Shin SS; Choi DW; Lim KM
    Toxicol In Vitro; 2016 Apr; 32():339-46. PubMed ID: 26867644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depigmentation caused by application of the active brightening material, rhododendrol, is related to tyrosinase activity at a certain threshold.
    Kasamatsu S; Hachiya A; Nakamura S; Yasuda Y; Fujimori T; Takano K; Moriwaki S; Hase T; Suzuki T; Matsunaga K
    J Dermatol Sci; 2014 Oct; 76(1):16-24. PubMed ID: 25082450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.